tirzepatide articles 🧠 reduces food energy intake by impacting brain areas controlling ingestive behavior. This small Phase 1 RCT (n=114) explored how tirzepatide changes eating behavior—and the brain's response to food—in people with Tirzepatide: a new low for

They're okay with slower progress if it means they can function at work, avoid nausea, and feel like themselves while the weight comes off

4 Instagram post

When I am struggling, kind gentle reminders of what my goals are inspire me to get back on track

The American Diabetes Association's Diabetes Plate Method (filling half your plate with non-starchy vegetables, one-quarter with protein, and one-quarter with carbohydrates) provides a helpful visual guide for meal composition

GLP-1Rs are expressed in the pancreas, intestinal intraepithelial lymphocytes, myocardium, adipose tissue, kidney, liver, blood vessels, lungs and in the CNS.2,3 Although GLP-1 is known for its incretin effect, which it shares with glucose-dependent insulinotropic peptide (GIP), the intake-regulating action, essential for its efficacy against obesity, occurs through its interaction with receptors located in the CNS.1,5 The GLP-1 peptide can reach the central nervous system (CNS) via peripheral vagal afferents, which transmit its action through the nodose ganglion to the nucleus tactus solitarius (NTS)